Showing results (31-40 of 179) with videos related to
Sort By:
Pageof 18
Blood|May 10, 2003
Induction of FucT-VII by the Ras/MAP kinase cascade in Jurkat T cellsSheila M Barry, Dimitrios G Zisoulis, Joel W Neal, et al.The Oncologist|August 22, 2018
Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective StudyLijia Xie, Seema Nagpal, Heather A Wakelee, et al.Cancer Medicine|December 18, 2024
Real-World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)-Mutant Metastatic Non-Small Cell Lung Cancer, From a US-Based Clinico-Genomic DatabaseSarah Waliany, Misako Nagasaka, Leah Park, et al.American Journal of Ophthalmology|July 20, 2015
Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer TherapyLoh-Shan B Leung, Joel W Neal, Heather A Wakelee, et al.Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutationsSamantha X Y Wang, Li Lei, Haiwei H Guo, et al.Annals of Translational Medicine|January 20, 2023
Diagnosis and treatment of pericardial mesothelioma by mediastinal mass resection: a case reportLubiao Liang, Xiao Zhang, Xixian Ke, et al.Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Pemetrexed in patients with thymic malignancies previously treated with chemotherapyYing Liang, Sukhmani K Padda, Jonathan W Riess, et al.JACC. Cardiooncology|March 6, 2023
Pharmacovigilance Analysis of Heart Failure Associated With Anti-HER2 Monotherapies and Combination Regimens for CancerSarah Waliany, Jennifer Caswell-Jin, Fauzia Riaz, et al.Lung Cancer (Amsterdam, Netherlands)|July 8, 2015
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interactionMillie Das, Sukhmani K Padda, Adam Frymoyer, et al.Anticancer Research|February 11, 2015
GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarrayJonathan W Riess, Robert West, Michelle Dean, et al.Pageof 18